SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Titan Biotech informs about Outcome of Board meeting

28 Sep 2015 Evaluate

Titan Biotech has informed that the Board of Directors of the Company at its meeting held on September 28, 2015, has approved postal ballot notice for sending to the shareholder for alteration / substitution Memorandum of Association of the Company, alteration/ substitution of Articles of Associations of the Company, approval for Investments/ Loans /Guarantees/ Securities/ Credit Facilities, and borrowing Money beyond the Paid up Capital and Free Reserves of Company and Creation of Charges on Company property. The e-voting shall commence on October 15, 2015 at 10:00 A.M. and ends on October 30, 2015, at 5:00 P.M. Further, the Company has submitted a copy of the Calendar of events.

The above information is a part of company’s filings submitted to BSE.

Titan Bio-Tech Share Price

462.95 -2.70 (-0.58%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×